Frankfurt - Delayed Quote EUR

Outlook Therapeutics, Inc. (41O.F)

Compare
1.9700
-0.0700
(-3.43%)
At close: January 24 at 3:29:02 PM GMT+1

Insider Purchases Last 6 Months

SharesTransactions
Purchases 0 0
Sales -- 0
Net Shares Purchased (Sold) 0 0
Total Insider Shares Held 8.42M --
% Net Shares Purchased (Sold) -- --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
SUKHTIAN GHIATH M Director and Beneficial Owner of more than 10% of a Class of Security Conversion of Exercise of derivative security at price 2.23 per share. Indirect 7,712,613 Jan 17, 2025
KENYON LAWRENCE A. Chief Financial Officer Purchase at price 5.69 per share. Direct 28,446 Sep 26, 2024
SYNTONE VENTURES, L.L.C. Beneficial Owner of more than 10% of a Class of Security Purchase at price 8.62 per share. Direct 6,157,145 Apr 15, 2024
HADDADIN YEZAN MUNTHER Director Purchase at price 11.82 per share. Direct 22,242 Mar 28, 2024
SUKHTIAN GHIATH M Director and Beneficial Owner of more than 10% of a Class of Security Stock Award(Grant) at price 0.00 per share. Indirect 0 Mar 18, 2024
EVANSON JEFF Officer Purchase at price 0.42 per share. Direct 26,243 Mar 7, 2024
DAGNON TERRY Chief Operating Officer Sale at price 1.14 per share. Direct 590,200 Apr 20, 2023

Related Tickers